Pain Ther (2013) 2:73 DOI 10.1007/s40122-013-0013-z
ERRATUM
Erratum to: Review of Lidocaine/Tetracaine Cream as a Topical Anesthetic for Dermatologic Laser Procedures Tina Alster
To view enhanced content go to www.paintherapy-open.com Published online: May 16, 2013 Ó The Author(s) 2013. This article is published with open access at Springerlink.com
ERRATUM TO: PAIN THER DOI 10.1007/S40122-013-0010-2 The author of the above-mentioned paper would like to make the following adjustment to her article. In the last paragraph of the ‘Current Treatments’ section, the sentence currently reads ‘Lidocaine/tetracaine cream (PliaglisÒ, Galderma Laboratories, Texas, USA) is the first Food and Drug Administration (FDA)-approved stable compounded mixture of 7 % lidocaine
stable eutectic mixture of 7 % lidocaine and 7 % tetracaine cream.’ This change has also been made to the article summary slide (available at: http://www.pain therapy-open.com/). The author thanks Springer Healthcare for publishing the correction.
OPEN ACCESS This article is distributed under the terms of the
and 7 % tetracaine cream.’ This sentence should read ‘Lidocaine/tetracaine cream (PliaglisÒ,
Creative Commons Attribution Noncommercial License which permits any noncommercial use,
Galderma Laboratories, Texas, USA) is the first
distribution, and reproduction in any medium,
Food and Drug Administration (FDA)-approved
provided the original author(s) and the source are credited.
The online version of the original article can be found under doi:10.1007/s40122-013-0010-2. T. Alster (&) Washington Institute of Dermatologic Laser Surgery, 1430K St NW Suite 200, Washington, D.C. 20005, USA e-mail: [email protected]
Enhanced content for this article is available on the journal web site: www.paintherapy-open.com
123
ERRATUM
Erratum to: Review of Lidocaine/Tetracaine Cream as a Topical Anesthetic for Dermatologic Laser Procedures Tina Alster
To view enhanced content go to www.paintherapy-open.com Published online: May 16, 2013 Ó The Author(s) 2013. This article is published with open access at Springerlink.com
ERRATUM TO: PAIN THER DOI 10.1007/S40122-013-0010-2 The author of the above-mentioned paper would like to make the following adjustment to her article. In the last paragraph of the ‘Current Treatments’ section, the sentence currently reads ‘Lidocaine/tetracaine cream (PliaglisÒ, Galderma Laboratories, Texas, USA) is the first Food and Drug Administration (FDA)-approved stable compounded mixture of 7 % lidocaine
stable eutectic mixture of 7 % lidocaine and 7 % tetracaine cream.’ This change has also been made to the article summary slide (available at: http://www.pain therapy-open.com/). The author thanks Springer Healthcare for publishing the correction.
OPEN ACCESS This article is distributed under the terms of the
and 7 % tetracaine cream.’ This sentence should read ‘Lidocaine/tetracaine cream (PliaglisÒ,
Creative Commons Attribution Noncommercial License which permits any noncommercial use,
Galderma Laboratories, Texas, USA) is the first
distribution, and reproduction in any medium,
Food and Drug Administration (FDA)-approved
provided the original author(s) and the source are credited.
The online version of the original article can be found under doi:10.1007/s40122-013-0010-2. T. Alster (&) Washington Institute of Dermatologic Laser Surgery, 1430K St NW Suite 200, Washington, D.C. 20005, USA e-mail: [email protected]
Enhanced content for this article is available on the journal web site: www.paintherapy-open.com
123
